Infextious Therapeutic is an AJK Biopharmaceutical company founded in 2018. Its mission is combating the life–threatening infectious disease using a novel Cyclic Peptide platform. Its focus is on the clinical development of novel anti-infective therapeutic drugs with emphasis on developing antiviral peptides against SARS-COV2, herpes simplex (HSV), and human papilloma (HPV) viruses, Broad-spectrum antimicrobial peptides with activity against multi-drug resistant bacteria, and Antifungal peptides against Onychomycosis.